More articles from Cancer Therapy: Clinical

Phase I Trial of ¹³¹I-huA33 in Patients with Advanced Colorectal Carcinoma
Geoffrey Chong, Fook Thean Lee, Wendie Hopkins, Niall Tebbutt, Jonathan S. Cebon, Angela J. Mountain, Bridget Chappell, Anthony Papenfuss, Paul Schleyer, Paul U, Roger Murphy, Veronika Wirth, Fiona E. Smyth, Nicole Potasz, Aurora Poon, Ian D. Davis, Tim Saunder, Graeme J. O'Keefe, Antony W. Burgess, Eric W. Hoffman, Lloyd J. Old, Andrew M. Scott

Clinical Cancer Research Jul 2005, 11 (13) 4818-4826; DOI: 10.1158/1078-0432.CCR-04-2330
Systemic Administration of an Attenuated, Tumor-Targeting Salmonella typhimurium to Dogs with Spontaneous Neoplasia: Phase I Evaluation
Douglas H. Thamm, Ilene D. Kurzman, Ivan King, Zujin Li, Mario Sznol, Richard R. Dubielzig, David M. Vail, E. Gregory MacEwen

Clinical Cancer Research Jul 2005, 11 (13) 4827-4834; DOI: 10.1158/1078-0432.CCR-04-2510
Can Molecular Markers Predict When to Implement Treatment with Aromatase Inhibitors in Invasive Breast Cancer?
Sian Tovey, Barbara Dunne, Caroline J. Witton, Amanda Forsyth, Timothy G. Cooke, John M.S. Bartlett

Clinical Cancer Research Jul 2005, 11 (13) 4835-4842; DOI: 10.1158/1078-0432.CCR-05-0196
Association of Paclitaxel Pharmacokinetics with the Development of Peripheral Neuropathy in Patients with Advanced Cancer
Stephan Mielke, Alex Sparreboom, Seth M. Steinberg, Hans Gelderblom, Clemens Unger, Dirk Behringer, Klaus Mross

Clinical Cancer Research Jul 2005, 11 (13) 4843-4850; DOI: 10.1158/1078-0432.CCR-05-0298
Association between Polymorphisms in the DNA Repair Genes, XRCC1, APE1, and XPD and Acute Side Effects of Radiotherapy in Breast Cancer Patients
Jenny Chang-Claude, Odilia Popanda, Xiang-Lin Tan, Silke Kropp, Irmgard Helmbold, Dietrich von Fournier, Wulf Haase, Marie Luise Sautter-Bihl, Frederik Wenz, Peter Schmezer, Christine B. Ambrosone

Clinical Cancer Research Jul 2005, 11 (13) 4802-4809; DOI: 10.1158/1078-0432.CCR-04-2657
Immunologic Purging of Autologous Peripheral Blood Stem Cell Products Based on CD34 and CD133 Expression Can Be Effectively and Safely Applied in Half of the Acute Myeloid Leukemia Patients
Nicole Feller, Marjolein A. van der Pol, Taco Waaijman, Geert W.D. Weijers, Guus Westra, Gert J. Ossenkoppele, Gerrit J. Schuurhuis

Clinical Cancer Research Jul 2005, 11 (13) 4793-4801; DOI: 10.1158/1078-0432.CCR-05-0031
Delayed Disease Progression after Allogeneic Cell Vaccination in Hormone-Resistant Prostate Cancer and Correlation with Immunologic Variables
Agnieska Michael, Graham Ball, Nadine Quatan, Fatima Wushishi, Nick Russell, Joe Whelan, Prabir Chakraborty, David Leader, Michael Whelan, Hardev Pandha

Clinical Cancer Research Jun 2005, 11 (12) 4469-4478; DOI: 10.1158/1078-0432.CCR-04-2337
The Cyclin-Dependent Kinase Inhibitor UCN-01 Plus Cisplatin in Advanced Solid Tumors: A California Cancer Consortium Phase I Pharmacokinetic and Molecular Correlative Trial
Primo N. Lara, Philip C. Mack, Timothy Synold, Paul Frankel, Jeff Longmate, Paul H. Gumerlock, James H. Doroshow, David R. Gandara

Clinical Cancer Research Jun 2005, 11 (12) 4444-4450; DOI: 10.1158/1078-0432.CCR-04-2602
First Clinical Experience with α-Emitting Radium-223 in the Treatment of Skeletal Metastases
Sten Nilsson, Roy H. Larsen, Sophie D. Fosså, Lise Balteskard, Kari W. Borch, Jan-Erik Westlin, Gro Salberg, Øyvind S. Bruland

Clinical Cancer Research Jun 2005, 11 (12) 4451-4459; DOI: 10.1158/1078-0432.CCR-04-2244
Combination of Imatinib Mesylate with Autologous Leukocyte-Derived Heat Shock Protein and Chronic Myelogenous Leukemia
Zihai Li, Yi Qiao, Bei Liu, Elizabeth J. Laska, Priyamvadha Chakravarthi, Judith M. Kulko, Robert D. Bona, Min Fang, Upendra Hegde, Victor Moyo, Susan H. Tannenbaum, Antoine Ménoret, Judy Gaffney, Laura Glynn, Carolyn D. Runowicz, Pramod K. Srivastava

Clinical Cancer Research Jun 2005, 11 (12) 4460-4468; DOI: 10.1158/1078-0432.CCR-05-0250

Main menu

User menu

Search

More articles from Cancer Therapy: Clinical

Pages

Articles

Info for

About Clinical Cancer Research